Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2035
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
July 21 2017
Lisbon, September 11-15th 2017: Defymed will particpate at the 53rd annual meeting of the European A...
July 10 2017
Strasbourg, 10th July 2017: Targeted at persons suffering from diabetes (Type 1 diabetics and some T...